2021
DOI: 10.3390/ijms22062796
|View full text |Cite
|
Sign up to set email alerts
|

Treating Arterial Ageing in Patients with Diabetes: From Mechanisms to Effective Drugs

Abstract: Diabetes mellitus is a major healthcare problem. It is not only characterized by hyperglycemia and chronic complications, but in longer lasting diabetes and a longer living population, it is also associated with accelerated arterial ageing, which importantly contributes to cardiovascular complications. The accelerated arterial ageing in patients with diabetes should be considered separately from arterial ageing in patients without diabetes. Basic and clinical research have allowed better insight into the mecha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
12
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(14 citation statements)
references
References 115 publications
1
12
0
1
Order By: Relevance
“…Сообщается о положительном влиянии данного класса препаратов как на уровень АД, так и на показатели АЖ [18]. При приеме иАПФ у больных СД отмечалось увеличение активности брадикинина, снижение оксидативного стресса, повышение биодоступности оксида азота, снижение отложения коллагена в стенке сосуда [19].…”
Section: Relationships and Activities: Noneunclassified
“…Сообщается о положительном влиянии данного класса препаратов как на уровень АД, так и на показатели АЖ [18]. При приеме иАПФ у больных СД отмечалось увеличение активности брадикинина, снижение оксидативного стресса, повышение биодоступности оксида азота, снижение отложения коллагена в стенке сосуда [19].…”
Section: Relationships and Activities: Noneunclassified
“…Moreover, within the limit of the cross-sectional design of the analyses, we found that the presence of MAFLD potentiated the agerelated eGFR decline in every group which may be a result of the accelerated vessel ageing induced by the MAFLD-related metabolic disorders, consistent with data for diabetes-associated accelerated arterial ageing. 43 Independent of the involved mechanisms, MAFLD-associated glomerular hyperfiltration per se may be a major pathogenic factor for GFR decline and CKD progression. 9 Thus, mitigation of MAFLD and its risk factors, could be instrumental in ameliorating glomerular hyperfiltration and limiting MAFLD-associated accelerated GFR decline.…”
Section: Age-declining Egfr In Subjects With and Without Mafld Accord...mentioning
confidence: 99%
“…Endothelial dysfunction represents one of the earliest vascular complications in patients with diabetes and gradually leads to increased arterial stiffness 8 . Arterial elasticity generally deteriorates with age in the general population, and this effect is further amplified in patients with diabetes 9 . We hypothesized that vascular aging may be a risk factor for increased AoD; although the precise relationship between baPWV and AoD in patients with diabetes remains unclear.…”
Section: Introductionmentioning
confidence: 99%
“…8 Arterial elasticity generally deteriorates with age in the general population, and this effect is further amplified in patients with diabetes. 9 We hypothesized that vascular aging may be a risk factor for increased AoD; although the precise relationship between baPWV and AoD in patients with diabetes remains unclear.…”
mentioning
confidence: 99%